Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Mexico - Delayed Quote MXN

10x Genomics, Inc. (TXG.MX)

150.00
-5.77
(-3.70%)
As of April 4 at 8:34:22 AM CST. Market Open.
Loading Chart for TXG.MX
  • Previous Close 155.77
  • Open 0.00
  • Bid 159.00 x --
  • Ask 180.00 x --
  • Day's Range 150.00 - 150.00
  • 52 Week Range 150.00 - 822.81
  • Volume 0
  • Avg. Volume 28
  • Market Cap (intraday) 19.365B
  • Beta (5Y Monthly) 2.01
  • PE Ratio (TTM) --
  • EPS (TTM) -29.82
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

www.10xgenomics.com

1,306

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TXG.MX

View More

Performance Overview: TXG.MX

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TXG.MX
65.91%
S&P 500 (^GSPC)
7.08%

1-Year Return

TXG.MX
81.77%
S&P 500 (^GSPC)
7.77%

3-Year Return

TXG.MX
88.42%
S&P 500 (^GSPC)
27.94%

5-Year Return

TXG.MX
96.18%
S&P 500 (^GSPC)
92.67%

Compare To: TXG.MX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TXG.MX

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    19.36B

  • Enterprise Value

    13.27B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.51

  • Price/Book (mrq)

    1.33

  • Enterprise Value/Revenue

    1.11

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.90%

  • Return on Assets (ttm)

    -12.77%

  • Return on Equity (ttm)

    -25.17%

  • Revenue (ttm)

    610.79M

  • Net Income Avi to Common (ttm)

    -182.63M

  • Diluted EPS (ttm)

    -29.82

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    393.4M

  • Total Debt/Equity (mrq)

    11.63%

  • Levered Free Cash Flow (ttm)

    59.82M

Research Analysis: TXG.MX

View More

Company Insights: TXG.MX

Research Reports: TXG.MX

View More